Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells.
about
A multi-targeted approach to suppress tumor-promoting inflammationSustained proliferation in cancer: Mechanisms and novel therapeutic targetsFuling Granule, a Traditional Chinese Medicine Compound, Suppresses Cell Proliferation and TGFβ-Induced EMT in Ovarian CancerResveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathwayApoptotic Cell Death Induced by Resveratrol Is Partially Mediated by the Autophagy Pathway in Human Ovarian Cancer CellsDevelopment of an in vitro periodontal biofilm model for assessing antimicrobial and host modulatory effects of bioactive moleculesPhytochemicals: a multitargeted approach to gynecologic cancer therapy.Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expressionInhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cellsHigh Potency of a Novel Resveratrol Derivative, 3,3',4,4'-Tetrahydroxy-trans-stilbene, against Ovarian Cancer Is Associated with an Oxidative Stress-Mediated Imbalance between DNA Damage Accumulation and RepairSensitization of Radioresistant Prostate Cancer Cells by Resveratrol Isolated from Arachis hypogaea Stems.Resveratrol, Acetyl-Resveratrol, and Polydatin Exhibit Antigrowth Activity against 3D Cell Aggregates of the SKOV-3 and OVCAR-8 Ovarian Cancer Cell Lines.Resveratrol and STAT inhibitor enhance autophagy in ovarian cancer cells.Autophagy and mitochondrial dysfunction in adjuvant-arthritis rats treatment with resveratrol.Resveratrol and acetyl-resveratrol modulate activity of VEGF and IL-8 in ovarian cancer cell aggregates via attenuation of the NF-κB protein.Resveratrol biosynthesis: plant metabolic engineering for nutritional improvement of food.Ellagic Acid and Resveratrol Prevent the Development of Cisplatin Resistance in the Epithelial Ovarian Cancer Cell Line A2780.Platinum-induced mitochondrial DNA mutations confer lower sensitivity to paclitaxel by impairing tubulin cytoskeletal organization.Antitumor activity of the dietary diterpene carnosol against a panel of human cancer cell lines.The paradoxical pro- and antiangiogenic actions of resveratrol: therapeutic applications in cancer and diabetes.The effect of resveratrol in combination with irradiation and chemotherapy: study using Merkel cell carcinoma cell lines.Comparative proteome profiling of breast tumor cell lines by gel electrophoresis and mass spectrometry reveals an epithelial mesenchymal transition associated protein signature.Preventing aging with stem cell rejuvenation: Feasible or infeasible?Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol suppresses ovarian cancer cell growth via inhibition of ERK and STAT3.Protective effects of the resveratrol analog piceid in dopaminergic SH-SY5Y cells.Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer Cells.Anticancer effects of novel resveratrol analogues on human ovarian cancer cells.Impaired JAK2-induced activation of STAT3 in failing human myocytes.Effect of CXCR4 silencing with shRNA on MAPK signaling in ovarian cancer.Resveratrol suppresses the epithelial-to-mesenchymal transition in PC-3 cells by down-regulating the PI3K/AKT signaling pathwaySPARCL1 suppresses the proliferation and migration of human ovarian cancer cells via the MEK/ERK signaling
P2860
Q28393278-3AB2300B-6662-488D-ACA6-E08B29694015Q28396388-C1297A1B-CE5D-4000-B604-5F073D17CA7FQ28468466-2BB8E895-A446-4213-BEFD-F60C003CC9B4Q28541242-A374B7B6-4D9C-43D5-9ABA-37AF325089AAQ28548163-865F6770-32A4-4B14-A1B0-04C4AFEECDBAQ33842829-465A015E-FB8C-4482-BBAD-7F3CE7F260A1Q33908881-754DCF55-6007-45A6-84FC-A0D1732E223EQ34518736-C7668407-901C-4360-9D23-B01898059528Q35185008-B3C74C08-0776-441C-AE8F-BC399DD61D75Q35538822-75DDF4F6-16E1-4152-9525-E25130025FA3Q35851696-B074A5D1-8FD3-4FCB-9E74-555B0807F02CQ36247494-B82149AE-DAE5-4401-8B49-252D62729543Q36296708-1563C78A-DCB1-4ED5-815E-D32EA169B381Q37164378-DE5D1586-9914-41A8-A189-85F0E542A750Q37244352-6452BAAF-B57F-423C-90FD-A9B130F14FDCQ37466290-1D89E8DA-0620-49F7-8BE7-B612875CC8CAQ38025006-493509ED-44D0-46A7-AD0A-6107124BBD15Q38355123-7677137A-B026-4BD4-B0BF-E21AC224ED8CQ38795677-58514882-EB4C-4941-861C-55DCE3891D0BQ39004130-B659968C-84F6-4538-8FC5-02A5C6E430F0Q39018218-8BD6A8FC-9DE2-4B9D-987F-957D54C6703FQ39066612-5CCA4146-57C7-4F6C-87B5-FC8B6E5FD2FEQ39224654-816E1731-C37E-41AB-A707-BD71DEB9608DQ42328789-226BBCDC-5D83-4BBF-A511-96B31F865F68Q47299200-AEB6A1E4-D6BA-4599-834D-64B7DC1E70E6Q48145523-3577897B-A9E6-4F08-8497-0DADF1F3A312Q48242191-8D9A9F9C-8230-4DD8-B84D-0DF869F0F089Q52622186-7B090BA8-865A-4F41-8390-942D456C9E57Q53057923-DA01731C-1D23-4805-A16E-6F900432132FQ54501635-32B077D7-0EFC-498B-85EC-59784EB696ADQ54977968-3BE44D7D-8FEB-4C1E-8862-82A2234A64D6Q58129736-D9FA525F-0020-44DE-81AC-047969059F0BQ58796673-41D7A38C-EE31-47EA-8F62-6A0D4EE4B917
P2860
Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Resveratrol downregulates Akt/ ...... OVCAR-3 ovarian cancer cells.
@en
Resveratrol downregulates Akt/ ...... OVCAR-3 ovarian cancer cells.
@nl
type
label
Resveratrol downregulates Akt/ ...... OVCAR-3 ovarian cancer cells.
@en
Resveratrol downregulates Akt/ ...... OVCAR-3 ovarian cancer cells.
@nl
prefLabel
Resveratrol downregulates Akt/ ...... OVCAR-3 ovarian cancer cells.
@en
Resveratrol downregulates Akt/ ...... OVCAR-3 ovarian cancer cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
Resveratrol downregulates Akt/ ...... OVCAR-3 ovarian cancer cells.
@en
P2093
Andrea Urbani
Daniela Toraldo
Michele Maffia
Piero Del Boccio
P2860
P304
P356
10.1039/C2MB05486H
P50
P577
2012-01-10T00:00:00Z